Please login to the form below

Not currently logged in
Email:
Password:

GW Pharma

This page shows the latest GW Pharma news and features for those working in and with pharma, biotech and healthcare.

US approval for first ever cannabis-based medicine

US approval for first ever cannabis-based medicine

GW Pharma has gained an historic approval for its drug Epidiolex, the first ever prescription medicine derived from cannabis. ... Once this recategorisation is completed within the next 90 days, GW Pharma will launch Epidiolex in the US.

Latest news

  • GW ascendant as epilepsy drug clears phase III trial GW ascendant as epilepsy drug clears phase III trial

    Cannabis-based drug specialist GW Pharma saw its shares soar yesterday after reporting impressive phase III results for its epilepsy drug candidate. ... GW has been scaling up its commercial organisation and production capacity in anticipation of

  • Almirall launches Sativex in Italy Almirall launches Sativex in Italy

    GW said that in order to monitor therapeutic accuracy and appropriateness, a National Register has been established in which patients in Italy who are treated with Sativex will be enrolled. ... Sativex has been given a rolling launch in Europe, with GW

  • Eisai pulls epilepsy drug Fycompa in Germany Eisai pulls epilepsy drug Fycompa in Germany

    In a statement, the Japan-based pharma company said it was “ unable to accept the assessment” made by the German Federal Joint Committee (G-BA) through the AMNOG system of pricing,

  • GW Pharma says German Sativex pricing GW Pharma says German Sativex pricing "unacceptable"

    GW Pharma says German Sativex pricing "unacceptable". May pull MS drug from market. ... In the latest development, an arbitration board has set a price "significantly lower than the reimbursed Sativex price in other European countries", according to GW

  • Mucosal drug delivery: beyond buccal

    Even assuming a new material passes approval stages, the pharma industry still faces the challenge of manufacturing it on a commercial scale, which is a completely different from making it in ... buprenorphine. Subutex. Reckitt Benckiser. pain relief.

More from news
Approximately 4 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Pharma deals during January 2014 Pharma deals during January 2014

    Another option, open to some European companies, is to raise cash in the US, for example, in early January GW Pharma raised $87.9m on NASDAQ. ... See a table listing all the major pharma mergers, acquisitions and collaborations agreed during January 2014.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • GW Pharmaceuticals promotes Adam George to MD GW Pharmaceuticals promotes Adam George to MD

    GW Pharmaceuticals promotes Adam George to MD. And Scott Giacobello joins as chief financial officer. ... UK biopharma company GW Pharmaceuticals has promoted chief financial officer Adam George to UK managing director.

  • GW Pharma appoints Julian Gangolli as North American president GW Pharma appoints Julian Gangolli as North American president

    GW Pharma appoints Julian Gangolli as North American president. Appointment coincides with GW Pharma’ s US launch. ... Biopharma company GW Pharma has named Julian Gangolli as its president for North America.

  • GW hires Pfizer’s Kenneth Sommerville GW hires Pfizer’s Kenneth Sommerville

    GW hires Pfizer’ s Kenneth Sommerville. Appointed VP clinical research at company specialising in cannabinoids. ... Dr Kenneth Sommerville has left his role at pharma giant Pfizer to join GW Pharma.

More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics